IDMA | Zee News

Advertisement

IDMA News

24 Apr 2020

India’s current production capacity of HCQ is 35-40 cr tablets a month: IDMA

Senior vice president of Indian Drug Manufacturers’ Association (IDMA), Viranchi Shah said that India’s current production capacity of Hydroxychloroquine is 35-40 crore tablets a month. While speaking to ANI, he said, “India holds almost 70% global capacity of manufacturing Hydroxychloroquine (HCQ). Our current production capacity of Hydroxychloroquine is 35-40 crore tablets a month. This is 10 times more than our requirement. There is no shortage of HCQ in India and we have sufficient amount of it to supply outside.”

25 Jun 2014

IDMA seeks exemptions for R&D, samples

Indian Drug Manufacturers' Association (IDMA) Wednesday asked the government that 'control samples' and samples given to physicians be exempted from duties and taxes in the Budget.

Loading...

NEWS ON ONE CLICK